Xspray Pharma
Pre-clinicalXspray Pharma’s unique technology could improve the quality of life, and make it possible for more patients to access improved Protein Kinase Inhibitor (PKI) drugs for treatment of cancer.
Founded
2013
Focus
Oncology
About
Xspray Pharma’s unique technology could improve the quality of life, and make it possible for more patients to access improved Protein Kinase Inhibitor (PKI) drugs for treatment of cancer.
Funding History
3Total raised: $50M
IPO$25MCarnegie Investment BankJun 14, 2019
Series B$15MKarolinska DevelopmentMar 15, 2017
Series A$10MIndustrifondenJun 15, 2015
Company Info
TypePrivate
Founded2013
LocationStockholm, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile